bf/NASDAQ:ALNY_icon.jpeg

NASDAQ:ALNY

Alnylam Pharmaceuticals

  • Stock

255.13

−3.08%

−177.39

USD last updated 14/08 01:46:41

Last Close

432.52

13/08 20:38

Market Cap

32.60B

Beta: 0.48

Volume Today

1.40M

Avg: 846.05K

PE Ratio

−42.10

PFCF: −323.22

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marke...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -3-2-112017-02-082019-02-072021-02-112023-02-232024-11-07

    Revenue (Estimate*)

    200M400M600M800M2017-02-082019-02-072021-02-112023-02-232024-11-07

    *Estimate based on analyst consensus